Skip to content
Application 215566
- Type
- ANDA
- Sponsor
- COREPHARMA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM | TABLET;ORAL | 3.75MG | No | No |
| 002 | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM | TABLET;ORAL | 7.5MG | No | No |
| 003 | CLORAZEPATE DIPOTASSIUM | CLORAZEPATE DIPOTASSIUM | TABLET;ORAL | 15MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 60505-4754 | Clorazepate Dipotassium | Clorazepate Dipotassium | Apotex Corp. | ANDA | Current |
| 60505-4755 | Clorazepate Dipotassium | Clorazepate Dipotassium | Apotex Corp. | ANDA | Current |
| 60505-4756 | Clorazepate Dipotassium | Clorazepate Dipotassium | Apotex Corp. | ANDA | Current |